StemCell InstituteJP:7096
| Mar 31, 2019 | Mar 31, 2020 | Mar 31, 2021 | Mar 31, 2022 | Mar 31, 2023 | Mar 31, 2024 |
---|
Profit (loss) before income taxes | 215 | 383 | 91 | 213 | 279 | 441 |
---|
Depreciation | 35 | 32 | 33 | 97 | 105 | 121 |
---|
Head office relocation expenses-OpeCF | - | - | - | - | 21 | - |
---|
Increase (decrease) in allowance for doubtful accounts | -0 | 0 | -1 | 1 | 2 | 0 |
---|
Increase (decrease) in provision for bonuses | 3 | 16 | 5 | -1 | 6 | 2 |
---|
Increase (decrease) in provision for retirement benefits for directors (and other officers) | - | 3 | 3 | 3 | 12 | 7 |
---|
Interest and dividend income | -0 | -0 | -0 | -1 | -2 | -4 |
---|
Loss on retirement of non-current assets | 1 | - | 1 | - | - | 0 |
---|
Loss (gain) on sale of investment securities | - | 0 | - | - | - | -22 |
---|
Decrease (increase) in trade receivables | -104 | -101 | -1 | -314 | -546 | -447 |
---|
Decrease (increase) in inventories | -2 | -3 | -16 | -8 | 1 | -3 |
---|
Increase (decrease) in trade payables | 6 | 0 | 4 | 9 | 0 | 5 |
---|
Increase (decrease) in accounts payable - other | -16 | -11 | 7 | 8 | 6 | 10 |
---|
Increase (decrease) in accrued consumption taxes | 15 | 26 | -47 | 57 | -17 | 4 |
---|
Increase (decrease) in advances received | 268 | 423 | 337 | 330 | 350 | 325 |
---|
Other, net | 5 | -7 | -6 | 4 | -10 | 4 |
---|
Subtotal | 426 | 762 | 358 | 461 | 207 | 442 |
---|
Interest and dividends received | 0 | 0 | 0 | 0 | 2 | 3 |
---|
Income taxes paid | -35 | -94 | -124 | -14 | -109 | -111 |
---|
Net cash provided by (used in) operating activities | 391 | 668 | 239 | 469 | 100 | 335 |
---|
Payments into time deposits | -751 | -751 | -751 | - | - | -500 |
---|
Proceeds from withdrawal of time deposits | 600 | 751 | 751 | 750 | 1 | - |
---|
Purchase of investment securities | - | - | -105 | - | -143 | -200 |
---|
Proceeds from sale of investment securities | - | - | - | - | - | 72 |
---|
Purchase of property, plant and equipment | -29 | -59 | -401 | -181 | -56 | -183 |
---|
Purchase of intangible assets | -0 | -6 | -2 | -23 | -4 | -18 |
---|
Payments of leasehold and guarantee deposits | -0 | -40 | -9 | -9 | -48 | -7 |
---|
Other, net | -3 | -3 | -3 | 1 | -35 | 24 |
---|
Net cash provided by (used in) investing activities | -184 | -108 | -520 | 404 | -285 | -812 |
---|
Repayments of lease liabilities | - | - | - | - | -1 | -1 |
---|
Purchase of treasury shares | - | - | - | - | -0 | - |
---|
Net cash provided by (used in) financing activities | - | - | - | 644 | -1 | -1 |
---|
Net increase (decrease) in cash and cash equivalents | 207 | 560 | -281 | 1,518 | -186 | -478 |
---|